ELISABETH BORKOWSKI: Open Payments
NPI 1154192854 · EASTHAMPTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,182 in 40 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,182
Food & beverage: $1,182
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 6 | $266 |
| Regeneron Healthcare Solutions, Inc. | 8 | $255 |
| AstraZeneca Pharmaceuticals LP | 7 | $243 |
| Amgen Inc. | 5 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $84 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| Incyte Corporation | 1 | $24 |
| GENZYME CORPORATION | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
Products named: TEZSPIRE, DUPIXENT, Hizentra, Andembry, FASENRA, NEFFY, TAKHZYRO, CUVITRU.
Industry payments across MA — which companies pay providers there.
